istradefylline
Selected indexed studies
- Istradefylline. (, 2012) [PMID:34787989]
- The role of istradefylline in the Parkinson's disease armamentarium. (Expert Opin Pharmacother, 2023) [PMID:37029952]
- Istradefylline - a first generation adenosine A(2A) antagonist for the treatment of Parkinson's disease. (Expert Rev Neurother, 2021) [PMID:33507105]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Istradefylline. (2012) pubmed
- The role of istradefylline in the Parkinson's disease armamentarium. (2023) pubmed
- Istradefylline - a first generation adenosine A(2A) antagonist for the treatment of Parkinson's disease. (2021) pubmed
- Istradefylline: adenosine A2A receptor antagonist to reduce "OFF" time in Parkinson's disease. (2020) pubmed
- Istradefylline for OFF Episodes in Parkinson's Disease: A US Perspective of Common Clinical Scenarios. (2022) pubmed
- Istradefylline for the treatment of Parkinson's disease: is it a promising strategy? (2018) pubmed
- Efficacy and safety of istradefylline for Parkinson's disease: A systematic review and meta-analysis. (2022) pubmed
- Comparative Safety of Istradefylline Among Parkinson Disease Adjunctive Therapies: A Systematic Review and Meta-analysis of Randomized Controlled Studies. (2025) pubmed
- The safety of istradefylline for the treatment of Parkinson's disease. (2015) pubmed
- Istradefylline to Treat Patients with Parkinson's Disease Experiencing "Off" Episodes: A Comprehensive Review. (2020) pubmed